Dr. Trevor Reichman

Dr. Bernardini is an Associate Professor in the Department of Obstetrics and Gynecology at the University of Toronto, the Division Head of Gynecologic Oncology at the University Health Network, and an Associate Scientist at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital. Dr. Bernardini, a graduate of the University of Western Ontario, then pursued a combined fellowship in gynecologic oncology at the University of Toronto and Duke University Medical Center after completing his residency and earning a master's degree in laboratory and pathobiology at the University of Toronto. Associate professor at the University of Toronto, Dr. Bernardini has won honours for both teaching and research, including the 2014 ""Award for Teaching Excellence"" and the 2018 ""Senior Merit Award"" (research). He is the co-director of the Women's College Prevent Ovarian Cancer Program and heads the UHN robotic surgery programme. Understanding the function of precursor lesions in high grade serous ovarian cancer and cytoreductive surgery for later stage illness are among his research interests. He is the Lead Investigator of the Early Stage Cohort for the CANSTAMP trial investigating new approaches to front-line therapy in serous and/or p53 abnormal/mutant endometrial cancer, and he co-leads the ovarian cytoreductive programme as well as CANSTIC, a pan-Canadian study looking at treatment and outcomes of ovarian pre-cursor lesions.

Qualification

• FRCSC
• MD